(2020). Cellular mechanisms triggered by the cotreatment of resveratrol and doxorubicin in breast cancer: A translational in vitro–In silico model.
Chicago Style (17th ed.) CitationCellular Mechanisms Triggered by the Cotreatment of Resveratrol and Doxorubicin in Breast Cancer: A Translational in Vitro–In Silico Model. 2020.
MLA (8th ed.) CitationCellular Mechanisms Triggered by the Cotreatment of Resveratrol and Doxorubicin in Breast Cancer: A Translational in Vitro–In Silico Model. 2020.
Warning: These citations may not always be 100% accurate.